# Theophylline (Anhydrous)

NDC: 69367-415
Generic name: Theophylline Anhydrous
Labeler / Manufacturer: Westminster Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20251125

FDA application: ANDA040560

## Active ingredients

- THEOPHYLLINE ANHYDROUS: 600 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69367-415"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69367-415
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04f1d1da-ce61-45b3-acf4-903cc81d16da